- Home
- TEVA vs ONON Comparison
TEVA vs ONON Comparison
Compare TEVA & ONON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEVA
- ONON
- Stock Information
- Founded
- TEVA 1901
- ONON 2010
- Country
- TEVA Israel
- ONON Switzerland
- Employees
- TEVA N/A
- ONON N/A
- Industry
- TEVA Biotechnology: Pharmaceutical Preparations
- ONON Shoe Manufacturing
- Sector
- TEVA Health Care
- ONON Consumer Discretionary
- Exchange
- TEVA Nasdaq
- ONON Nasdaq
- Market Cap
- TEVA 20.1B
- ONON 19.4B
- IPO Year
- TEVA N/A
- ONON 2021
- Fundamental
- Price
- TEVA $16.76
- ONON $52.48
- Analyst Decision
- TEVA Strong Buy
- ONON Strong Buy
- Analyst Count
- TEVA 8
- ONON 20
- Target Price
- TEVA $24.50
- ONON $61.90
- AVG Volume (30 Days)
- TEVA 10.1M
- ONON 5.7M
- Earning Date
- TEVA 07-30-2025
- ONON 08-12-2025
- Dividend Yield
- TEVA N/A
- ONON N/A
- EPS Growth
- TEVA N/A
- ONON 61.26
- EPS
- TEVA N/A
- ONON 0.71
- Revenue
- TEVA $16,616,000,000.00
- ONON $2,869,732,450.00
- Revenue This Year
- TEVA $5.69
- ONON $29.06
- Revenue Next Year
- TEVA N/A
- ONON $24.47
- P/E Ratio
- TEVA N/A
- ONON $76.34
- Revenue Growth
- TEVA 3.82
- ONON 34.92
- 52 Week Low
- TEVA $12.47
- ONON $34.59
- 52 Week High
- TEVA $22.80
- ONON $64.05
- Technical
- Relative Strength Index (RSI)
- TEVA 47.80
- ONON 46.44
- Support Level
- TEVA $16.55
- ONON $51.19
- Resistance Level
- TEVA $17.30
- ONON $55.95
- Average True Range (ATR)
- TEVA 0.39
- ONON 1.62
- MACD
- TEVA -0.05
- ONON 0.06
- Stochastic Oscillator
- TEVA 38.89
- ONON 43.27
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About ONON On Holding AG
On Holding AG is a premium performance sports brand rooted in technology, design, and impact. Its shoes, apparel, and accessories products are designed predominantly for athletic use, casual, or leisure purposes. It does not manufacture the products or the raw materials and relies instead on third-party suppliers and contract manufacturers. Geographically, it derives a majority of its revenue from the Americas and rest from Europe, Middle East and Africa and Asia-Pacific region.